Latest / The Well-Built Life / Thyroid Insights: Controversies
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:04Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:08Speaker 1: you are tuning in. We are here to cut through
- 0:11Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:15Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:19Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:24Speaker 1: and let's dive in. Alright Thomas, let's start with the
- 0:27Speaker 1: thyroid's historical journey. You know, it's amazing how much we
- 0:31Speaker 1: have learned from the early 1880s to today. What's the
- 0:36Speaker 1: first big milestone you think we should cover?
- 0:39Speaker 2: Great point, Rachel. The 1880s saw the first big breakthrough. Scent.
- 0:46Speaker 2: Gerge performed thyroidectomies, and his work led to the isolation
- 0:51Speaker 2: of thyroid extract. It was quite a revolutionary step. What
- 0:55Speaker 2: do you think? How did that impact the field? Well.
- 0:58Speaker 1: It really laid the groundwork for understanding thyroid disorders. But
- 1:02Speaker 1: the next big leap came in 1913, right? Edward Calvin
- 1:06Speaker 1: Kendall and his team identified the thyroid hormone. That had
- 1:11Speaker 1: to have been a pivotal moment, didn't it?
- 1:13Speaker 2: Absolutely. That discovery opened up new avenues for research. We
- 1:18Speaker 2: started to understand how this hormone actually works. And speaking
- 1:22Speaker 2: of working … The introduction of synthetic levothyroxine in 1955
- 1:27Speaker 2: by A. Kendall was a game changer. It made treatment
- 1:30Speaker 2: more accessible and reliable.
- 1:32Speaker 1: Yes. And from there, the 1960s brought a lot more detail.
- 1:38Speaker 1: The introduction of T3 as a separate hormone and focusing
- 1:42Speaker 1: on TSH as a diagnostic marker were crucial. How does
- 1:47Speaker 1: that change compared to what we know today?
- 1:49Speaker 2: It really refined our understanding. Back then, The focus was
- 1:53Speaker 2: more on T4, but now we understand that T3 is
- 1:57Speaker 2: crucial for metabolic processes. This shift in focus highlights how
- 2:01Speaker 2: continuously evolving our knowledge is.
- 2:03Speaker 1: Definitely. And just to add, the 1990s saw significant advancements
- 2:09Speaker 1: in how T4 is converted to T3 within tissues. That's
- 2:12Speaker 1: a fascinating breakthrough. How did this insight shape treatment approaches?
- 2:17Speaker 2: It made a huge difference. It allowed for more nuanced
- 2:21Speaker 2: diagnoses and treatments. For instance, we can now tailor treatments
- 2:26Speaker 2: more precisely, considering an individual's T4 to T3 conversion rates.
- 2:31Speaker 2: This personalized approach is key in managing thyroid disorders effectively. Right.
- 2:37Speaker 1: And as we move into the 2000s, the introduction of
- 2:40Speaker 1: free T4 and free T3 assays really enhanced our diagnostics.
- 2:46Speaker 1: This allowed for a more accurate assessment of thyroid function.
- 2:50Speaker 1: How did this shift the paradigm?
- 2:52Speaker 2: It was revolutionary. These assays provided a clearer picture of
- 2:56Speaker 2: what's actually happening in the body. It's like going from
- 2:59Speaker 2: a surface-level reading to a deep dive, and the 2010s
- 3:03Speaker 2: continued this trend by focusing more on subclinical hypothyroidism and
- 3:08Speaker 2: thyroid autoimmunity, which opened up new areas of research.
- 3:12Speaker 1: Exactly. It's all about precision and understanding the subtle nuances
- 3:16Speaker 1: of thyroid health. And we can't forget about the current debates,
- 3:21Speaker 1: which include optimal TSH levels and the role of T3
- 3:24Speaker 1: in treatment. These conversations keep pushing the boundaries of what's
- 3:29Speaker 1: understood and what treatments are effective.
- 3:31Speaker 2: Absolutely. And with ongoing research, we might see even more breakthroughs.
- 3:36Speaker 2: It's a fascinating field with so much to explore. It's
- 3:40Speaker 2: not just about treatment, but also understanding how environmental factors
- 3:44Speaker 2: and lifestyle play into thyroid health. How do you think
- 3:47Speaker 2: all of this plays out in the clinic?
- 3:49Speaker 1: Good question, Thomas. Clinicians are really juggling these considerations. They
- 3:54Speaker 1: have to balance conventional diagnostics with patient-reported symptoms, recognizing that
- 3:59Speaker 1: traditional lab tests might not always tell the full story.
- 4:04Speaker 1: It's about finding the right balance.
- 4:05Speaker 2: So, let's dive into the nitty-gritty of thyroid function. Thomas,
- 4:11Speaker 2: it's fascinating how the thyroid gland works behind the scenes.
- 4:14Speaker 2: Can you walk us through the process of T4 being
- 4:17Speaker 2: converted into T3 and how this impacts metabolic processes?
- 4:21Speaker 1: Absolutely, and it's a multi-step process filled with complexity. The
- 4:25Speaker 1: thyroid gland synthesizes and secretes T4 thyroxine, which is then
- 4:30Speaker 1: transported to other tissues. From there, T4 is converted into
- 4:35Speaker 1: T3 triadotheranine via diodenases enzymes. This conversion is crucial because
- 4:41Speaker 1: T3 is much more potent and has a more direct
- 4:44Speaker 1: effect on metabolizing functions.
- 4:47Speaker 2: Exactly. Think of it as a two-way street. In the liver, heart,
- 4:51Speaker 2: and brain, T4 encounters deodenase enzymes that strip off iodine atoms,
- 4:56Speaker 2: turning it into T3. This highlights the importance of a
- 5:00Speaker 2: balanced deodenase activity for optimal function. Right.
- 5:03Speaker 1: And this conversion rate can vary widely between individuals. For example,
- 5:08Speaker 1: someone with a genetic predisposition or environmental factors affecting diodinous
- 5:13Speaker 1: enzymes might convert T4 into T3 at a different rate.
- 5:18Speaker 2: That's a great point. And it's not just genetics. Environmental
- 5:23Speaker 2: factors like stress and diet can also play a role.
- 5:27Speaker 2: For instance, certain foods high in goitrogens can interfere with
- 5:31Speaker 2: T4 to T3 conversion. Conversely, a well-balanced diet rich in selenium,
- 5:39Speaker 2: which is essential for diodinous enzymes, can support this process.
- 5:43Speaker 1: Precisely. Now, moving on to TSH regulation, it's fascinating to
- 5:48Speaker 1: see how the body maintains a delicate balance. TSH produced
- 5:52Speaker 1: by the pituitary gland acts as the primary regulator, but
- 5:56Speaker 1: its levels can be influenced by a range of factors,
- 5:58Speaker 1: including stress, diet, and even sleep patterns.
- 6:01Speaker 2: Yes, and the feedback loop is complex. High TSH levels
- 6:06Speaker 2: indicate an underactive thyroid, signaling increased TSH from the pituitary.
- 6:12Speaker 2: Low TSH levels, on the other hand, suggest an overactive thyroid.
- 6:16Speaker 2: But it's not as simple as just these two extremes.
- 6:19Speaker 2: There are nuances to consider.
- 6:21Speaker 1: Absolutely. For example, subclinical hypothyroidism, where TSH is elevated, but
- 6:28Speaker 1: T3 and T4 levels are within normal limits, presents a challenge.
- 6:33Speaker 1: In such cases, doctors might need to consider patient symptoms
- 6:37Speaker 1: and the overall context rather than just the lab results.
- 6:40Speaker 2: Exactly which brings up an interesting contradiction. Often, patients with
- 6:45Speaker 2: subclinical hypothyroidism have no symptoms, yet their TSH levels are
- 6:51Speaker 2: persistently high. This is where the gray area comes into play.
- 6:55Speaker 2: Clinicians need to balance conventional diagnostics with patient-reported symptoms, making
- 7:01Speaker 2: the process quite nuanced.
- 7:03Speaker 1: That's wild when you look at the raw numbers. According
- 7:06Speaker 1: to a recent NIH report, around 10-15% of the general
- 7:10Speaker 1: population experiences subclinical hypothyroidism. This underscores the need for more comprehensive,
- 7:17Speaker 1: diagnostic approaches.
- 7:19Speaker 2: Indeed, and the stakes are high. Untreated subclinical hypothyroidism can
- 7:24Speaker 2: lead to a variety of health issues, from cognitive decline
- 7:27Speaker 2: to cardiovascular problems, hence the importance of a holistic approach
- 7:32Speaker 2: that considers both clinical data and patient experiences.
- 7:35Speaker 1: So, diving into the diagnostic challenges, Let's look at the
- 7:39Speaker 1: lab-first versus symptom-first approaches. How do these methods play out
- 7:44Speaker 1: in practice? Thomas.
- 7:46Speaker 2: A great question, Rachel. The lab-first approach is often championed
- 7:51Speaker 2: by conventional endocrinologists. They rely heavily on TSH levels to
- 7:56Speaker 2: diagnose thyroid dysfunction, which can be too black and white.
- 8:01Speaker 2: What's your take on this?
- 8:02Speaker 1: For sure. While TSH is a good indicator, it's not
- 8:06Speaker 1: always the full picture. The lab-first approach can miss or
- 8:11Speaker 1: misinterpret subtle conditions like subclinical hypothyroidism. Have you seen cases
- 8:16Speaker 1: where this happened?
- 8:17Speaker 2: Absolutely. Take a patient with mild elevations in TSH we
- 8:22Speaker 2: will call her Jane. Her TSH is at the upper
- 8:25Speaker 2: end of normal, but she is presenting with chronic fatigue,
- 8:28Speaker 2: memory issues, and mood swings. A lab-first approach might just
- 8:33Speaker 2: label her as having a subclinical condition and move on.
- 8:36Speaker 2: But what Jane really needs is a more nuanced assessment.
- 8:40Speaker 1: Right? And that's the crucial nuance here. The symptom-first approach,
- 8:45Speaker 1: which often involves a thorough patient history and lifestyle evaluation,
- 8:49Speaker 1: can catch these subtleties. But it's not without its downsides, Thomas.
- 8:55Speaker 1: How does this approach hold up in practice?
- 8:58Speaker 2: Well, the symptom-first approach requires a lot of patience and
- 9:01Speaker 2: a good bedside manner. It involves asking detailed questions about diet,
- 9:06Speaker 2: environmental exposures, and past medical history. This can be time-consuming
- 9:12Speaker 2: and may not be prioritized in busy clinic settings. Plus,
- 9:15Speaker 2: some patients might not be aware of all the symptoms
- 9:18Speaker 2: they are experiencing, leading to incomplete histories.
- 9:21Speaker 1: Exactly, which brings up an interesting contradiction. We hear a
- 9:25Speaker 1: lot about patient empowerment and personalized medicine, yet the symptom-first
- 9:30Speaker 1: approach seems more labor-intensive for everyone involved. How do you
- 9:34Speaker 1: balance these demands?
- 9:35Speaker 2: It's a tough balance indeed, but consider the alternative. Missed
- 9:40Speaker 2: or misdiagnosed cases of subclinical hypothyroidism can lead to long-term
- 9:44Speaker 2: health issues. For instance, untreated subclinical hypothyroidism increases the risk
- 9:50Speaker 2: of cardiovascular problems and cognitive decline. A holistic approach that
- 9:54Speaker 2: combines both lab tests and detailed symptom assessments can help
- 9:59Speaker 2: prevent these issues.
- 10:00Speaker 1: That's a powerful point, Thomas. Speaking of which, how common
- 10:04Speaker 1: are these missed conditions, like subclinical hypothyroidism and thyroid autoimmune conditions?
- 10:10Speaker 1: They are not always front and center, right?
- 10:12Speaker 2: Not at all. Subclinical hypothyroidism is estimated to affect 10
- 10:17Speaker 2: to 15 percent of the population. while thyroid autoimmune conditions
- 10:22Speaker 2: like Hashimoto's affect around 4-5% of the general population Chapman 2022.
- 10:30Speaker 2: What we need is a diagnostic strategy that goes beyond
- 10:34Speaker 2: simple TSH levels.
- 10:35Speaker 1: And this is where the current controversies come into play.
- 10:39Speaker 1: We see both functional medicine practitioners advocating for lower TSH
- 10:43Speaker 1: thresholds and conventional medicine sticking to traditional guidelines. How do
- 10:49Speaker 1: these debates impact patient care, do you think?
- 10:52Speaker 2: It can create confusion for patients and practitioners alike. On
- 10:56Speaker 2: one hand, functional medicines focus on subclinical conditions can lead
- 11:00Speaker 2: to earlier interventions. On the other hand, the conventional medicine
- 11:05Speaker 2: approach might miss these cases. The challenge is to find
- 11:08Speaker 2: a balance that ensures comprehensive and effective care.
- 11:12Speaker 1: The debates over TSH ranges and the role of T4
- 11:14Speaker 1: to T3 conversion aren't just theoretical. they have real, world implications.
- 11:20Speaker 1: For instance, a meta-analysis by Smith et al. 2022 found
- 11:25Speaker 1: that sticking to narrower TSH ranges, 0.1-2.5 mL, in clinical
- 11:31Speaker 1: practice can lead to more overtreatment. This means higher dosages
- 11:36Speaker 1: of levothyroxine, which might not be necessary and could cause
- 11:39Speaker 1: side effects.
- 11:40Speaker 2: Exactly, and it's also important to consider the nuances. The
- 11:44Speaker 2: American Thyroid Association recommends a TSH range of 0.4 minus 4.0 mule,
- 11:51Speaker 2: but they note that patients with atrial fibrillation or a
- 11:54Speaker 2: history of thyroid cancer might warrant tighter ranges. This shows
- 11:58Speaker 2: the complexity in applying these guidelines across different patient populations.
- 12:02Speaker 1: Right, and that's the crucial nuance here. One size doesn't
- 12:06Speaker 1: fit all yet. In practice, Ture's pressure to follow one-size-fits-all
- 12:11Speaker 1: guidelines especially from insurers and healthcare systems. We see this
- 12:16Speaker 1: in functional medicine, where the focus is more on individualized care. Thomas,
- 12:22Speaker 1: how do these varying approaches play out differently in practice?
- 12:25Speaker 2: Let me illustrate with an example. In the conventional model,
- 12:29Speaker 2: patients might only get a TSH test if their primary
- 12:32Speaker 2: care physician suspects thyroid issues based on symptoms. But in
- 12:35Speaker 2: functional medicine, practitioners might test for TSH, free T4, and
- 12:41Speaker 2: free T3. along with looking at other markers like thyroid antibodies,
- 12:46Speaker 2: iodine levels, and nutrient status. This approach can catch issues
- 12:50Speaker 2: earlier but also adds more complexity.
- 12:52Speaker 1: That's wild when you look at the raw numbers. According
- 12:55Speaker 1: to DING 2023, about 20% of U.S. patients see functional
- 13:00Speaker 1: medicine practitioners, and this number is rising. This suggests a
- 13:05Speaker 1: growing demand for these personalized approaches, even if they come
- 13:09Speaker 1: with a higher initial cost. How do we balance the
- 13:13Speaker 1: benefits of these individualized strategies with the necessity of clear
- 13:17Speaker 1: guidelines for widespread clinical application?
- 13:20Speaker 2: It's a balancing act for sure. One way to address
- 13:23Speaker 2: this is through better communication and education between patients and providers.
- 13:28Speaker 2: For example, if a patient's TSH is slightly elevated, how
- 13:32Speaker 2: do we decide if they need treatment or if it's
- 13:34Speaker 2: a case of subclinical hypothyroidism that might resolve on its own?
- 13:39Speaker 2: This requires a nuanced conversation.
- 13:41Speaker 1: Exactly, and it's about finding that balance. Speaking of balance,
- 13:46Speaker 1: the T4 to T3 conversion aspect is equally contentious. Some
- 13:50Speaker 1: argue that T3 is more bioactive and thus more critical
- 13:54Speaker 1: for treatment, especially in conditions like fibromyalgia and depression. Wendland, 2023.
- 14:02Speaker 1: But others say that T4 is sufficient and that converting
- 14:05Speaker 1: to T3 in tissues is adequate.
- 14:08Speaker 2: That's precisely the kind of dynamic we see. It's not
- 14:11Speaker 2: as simple as just focusing on TSH or T3 levels.
- 14:15Speaker 2: It's about understanding the whole picture. Wendland's 2023 study found
- 14:20Speaker 2: that T3 levels are indeed low in fibromyalgia patients, but
- 14:24Speaker 2: whether increasing T3 levels directly improves symptoms is still up
- 14:28Speaker 2: for debate.
- 14:28Speaker 1: And this gets us back to the original question. How
- 14:31Speaker 1: do these debates impact patient care? It's about finding practical
- 14:35Speaker 1: solutions that can be adopted in real-world settings. For instance,
- 14:41Speaker 1: integrating advanced testing while not overwhelming patients with too many choices.
- 14:47Speaker 1: This is the kind of careful, balanced approach we need.
- 14:50Speaker 2: Agreed. The key is to ensure that patients have clear,
- 14:53Speaker 2: understandable information and that providers can navigate these complex guidelines effectively.
- 14:59Speaker 2: It's about empowering patients to make informed decisions and ensuring
- 15:02Speaker 2: that care is as individualized as possible without veering into overtreatment.
- 15:07Speaker 1: So, moving forward. Let's explore the future outlook for thyroid
- 15:10Speaker 1: health care. What does the integration of lifestyle factors and
- 15:15Speaker 1: alternative treatments mean for patients and providers?
- 15:18Speaker 2: Right, Rachel. It's about striking a balance between conventional medical
- 15:22Speaker 2: practices and holistic approaches. For instance, functional medicine practitioners are
- 15:27Speaker 2: increasingly recommending lifestyle changes that complement conventional treatments like diet,
- 15:32Speaker 2: stress reduction, and even environmental detoxification.
- 15:36Speaker 1: Exactly. Which brings up an interesting contradiction. While patients are
- 15:40Speaker 1: seeking more integrated care, some conventional practitioners might still be
- 15:45Speaker 1: wary of these alternative methods. How can we bridge this gap?
- 15:49Speaker 2: That's a great point, Rachel. One way is through public
- 15:52Speaker 2: health campaigns that educate both patients and practitioners about the
- 15:56Speaker 2: benefits of a more holistic approach. For example, showing how
- 16:00Speaker 2: certain lifestyle changes, like reducing exposure to environmental toxins, can
- 16:06Speaker 2: significantly improve thyroid function and overall health.
- 16:09Speaker 1: That's wild when you look at the raw numbers. Studies
- 16:12Speaker 1: suggest that 30 to 50% of patients might benefit from
- 16:15Speaker 1: these lifestyle interventions alone. Smith et al., 2022. It's not
- 16:20Speaker 1: just about treating the symptoms, but understanding the root causes.
- 16:24Speaker 2: Absolutely. And the good news is to raise growing support
- 16:27Speaker 2: for this integrated model. The American Thyroid Association itself is
- 16:32Speaker 2: pushing for more inclusive guidelines that consider patient-specific factors. This
- 16:37Speaker 2: means customizing treatment plans based on individual needs rather than
- 16:42Speaker 2: one-size-fits-all solutions.
- 16:44Speaker 1: Which is crucial, considering the diverse presentations of thyroid conditions.
- 16:49Speaker 1: For instance, subclinical hypothyroidism might manifest differently in each patient,
- 16:55Speaker 1: requiring personalized approaches. Indeed.
- 16:58Speaker 2: The future of thyroid healthcare is moving away from fixed
- 17:01Speaker 2: protocols toward more flexible, patient-centered models. This shift is driven
- 17:07Speaker 2: by both data and patient demand. As more research emerges,
- 17:12Speaker 2: we see a trend toward evidence-based practices that incorporate lifestyle factors.
- 17:17Speaker 1: Right, and that's where the real innovation lies. It's about
- 17:21Speaker 1: moving beyond just medication and looking at the bigger picture.
- 17:25Speaker 1: For example, incorporating regular exercise. which can boost thyroid function
- 17:30Speaker 1: and metabolism.
- 17:31Speaker 2: Exactly. And the benefits of these lifestyle changes aren't limited
- 17:35Speaker 2: to just thyroid health. They can have a ripple effect
- 17:38Speaker 2: on overall wellness. For instance, managing stress through mindfulness practices
- 17:43Speaker 2: can reduce cortisol levels, which might help alleviate some thyroid symptoms.
- 17:47Speaker 1: That's a compelling argument. It's important to remember that these
- 17:52Speaker 1: lifestyle factors can be powerful tools for prevention and management. And,
- 17:58Speaker 1: As we continue to gather more data, we should see
- 18:01Speaker 1: these integrative approaches becoming more mainstream.
- 18:05Speaker 2: Absolutely. The key is continuing to research and document these methods.
- 18:09Speaker 2: With more evidence, we can tailor more effective treatments that
- 18:13Speaker 2: are not only medically sound but also align with patient
- 18:16Speaker 2: values and lifestyles.
- 18:18Speaker 1: That brings us to the end of today's episode. Thank
- 18:20Speaker 1: you so much for spending part of your day with me.
- 18:23Speaker 1: If you found this episode's tips helpful and want to
- 18:25Speaker 1: make sure you don't miss the next conversation, please take
- 18:28Speaker 1: a quick second to hit that subscribe or follow button
- 18:31Speaker 1: on whatever platform you are listening on. It's a completely
- 18:34Speaker 1: free way to support the show and helps more people
- 18:37Speaker 1: find us. This podcast is independently produced, so if you
- 18:41Speaker 1: are ever in a position where you would like to
- 18:42Speaker 1: help keep it running, we do accept small donations. You
- 18:46Speaker 1: can find a link right in the episode description below
- 18:49Speaker 1: to buy us a coffee or contribute what you can.
- 18:53Speaker 1: Every bit genuinely helps. Take care of yourself. Stay balanced.
- 18:57Speaker 1: And we will talk again soon.